Compliance in at-home studies comparable to site-based trials: study
May 24, 2022
Recent Clario research suggests that decentralized studies are a good option for cancer drug developers based on high-compliance rates in at-home oncology studies. Read the analysis of the research report from trusted industry outlet, Fierce Biotech.